BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16240274)

  • 1. [Update on prospective glaucoma intervention studies].
    Arend KO; Redbrake C
    Klin Monbl Augenheilkd; 2005 Oct; 222(10):807-13. PubMed ID: 16240274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients.
    Heijl A; Bengtsson B; Chauhan BC; Lieberman MF; Cunliffe I; Hyman L; Leske MC
    Ophthalmology; 2008 Sep; 115(9):1557-65. PubMed ID: 18378317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ocular hypertension and glaucoma: the contribution of large studies to daily practice].
    Bron A
    J Fr Ophtalmol; 2002 Jun; 25(6):641-54. PubMed ID: 12223955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment.
    Katz J
    Ophthalmology; 1999 Feb; 106(2):391-5. PubMed ID: 9951496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
    Bengtsson B; Leske MC; Hyman L; Heijl A;
    Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study.
    Miglior S; Torri V; Zeyen T; Pfeiffer N; Vaz JC; Adamsons I;
    Am J Ophthalmol; 2007 Aug; 144(2):266-275. PubMed ID: 17543874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The European Glaucoma Prevention Study and the Ocular Hypertension Treatment Study: why do two studies have different results?
    Parrish RK
    Curr Opin Ophthalmol; 2006 Apr; 17(2):138-41. PubMed ID: 16552248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study.
    ; Miglior S; Pfeiffer N; Torri V; Zeyen T; Cunha-Vaz J; Adamsons I
    Ophthalmology; 2007 Jan; 114(1):3-9. PubMed ID: 17070596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency doubling technology perimetry in open-angle glaucoma eyes with hemifield visual field damage: comparison of high-tension and normal-tension groups.
    Murata H; Tomidokoro A; Matsuo H; Tomita G; Araie M
    J Glaucoma; 2007 Jan; 16(1):9-13. PubMed ID: 17224743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporating corneal pachymetry into the management of glaucoma.
    Iester M; Mete M; Figus M; Frezzotti P
    J Cataract Refract Surg; 2009 Sep; 35(9):1623-8. PubMed ID: 19683164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of long-term progression in the early manifest glaucoma trial.
    Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z;
    Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratometry, optic disc dimensions, and degree and progression of glaucomatous optic nerve damage.
    Jonas JB; Stroux A; Martus P; Budde W
    J Glaucoma; 2006 Jun; 15(3):206-12. PubMed ID: 16778642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of 8 prospective, randomized, multicenter glaucoma trials.
    Panarelli JF; Banitt MR; Sidoti PA; Budenz DL; Singh K
    J Glaucoma; 2015 Jan; 24(1):64-8. PubMed ID: 23632410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glaucoma care and clinical profile in Priest Hospital, Thailand.
    Sothornwit N; Jenchitr W; Pongprayoon C
    J Med Assoc Thai; 2008; 91 Suppl 1():S111-8. PubMed ID: 18672602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of central corneal thickness in patients participating in a glaucoma screening programme and those who were examined in the glaucoma unit].
    Hufnagl C; Hitzl W; Hornykewycz K; Grabner G; Reitsamer HA
    Klin Monbl Augenheilkd; 2008 Feb; 225(2):151-4. PubMed ID: 18293267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pressure reduction after selective laser trabeculoplasty with two different laser systems and after argon laser trabeculoplasty--a controlled prospective clinical trial on 284 eyes].
    Best UP; Domack H; Schmidt V
    Klin Monbl Augenheilkd; 2007 Mar; 224(3):173-9. PubMed ID: 17385117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma.
    Parisi V; Miglior S; Manni G; Centofanti M; Bucci MG
    Ophthalmology; 2006 Feb; 113(2):216-28. PubMed ID: 16406535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.